Mark I. Aeder

1.5k total citations
53 papers, 1.1k citations indexed

About

Mark I. Aeder is a scholar working on Transplantation, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Mark I. Aeder has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Transplantation, 24 papers in Public Health, Environmental and Occupational Health and 19 papers in Surgery. Recurrent topics in Mark I. Aeder's work include Renal Transplantation Outcomes and Treatments (38 papers), Organ Donation and Transplantation (22 papers) and Organ Transplantation Techniques and Outcomes (15 papers). Mark I. Aeder is often cited by papers focused on Renal Transplantation Outcomes and Treatments (38 papers), Organ Donation and Transplantation (22 papers) and Organ Transplantation Techniques and Outcomes (15 papers). Mark I. Aeder collaborates with scholars based in United States, Japan and Canada. Mark I. Aeder's co-authors include Darren Stewart, Richard N. Formica, Anna Y. Kucheryavaya, David K. Klassen, Charles F. Shield, Bradley A. Warady, Christopher Bryan, Alan M. Luger, Nicole A. Turgeon and Gilbert Ross and has published in prestigious journals such as Journal of the American Society of Nephrology, Transplantation and American Journal of Transplantation.

In The Last Decade

Mark I. Aeder

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark I. Aeder United States 19 764 643 439 178 138 53 1.1k
Dolores Prats Spain 19 572 0.7× 582 0.9× 509 1.2× 102 0.6× 163 1.2× 50 1.0k
F. Oppenheimer Spain 16 538 0.7× 392 0.6× 279 0.6× 221 1.2× 78 0.6× 45 943
Geoffrey K. Dube United States 20 723 0.9× 593 0.9× 498 1.1× 79 0.4× 289 2.1× 43 1.5k
Jerry McCauley United States 21 914 1.2× 651 1.0× 309 0.7× 307 1.7× 170 1.2× 42 1.6k
Erica Hartmann United States 21 1.1k 1.4× 877 1.4× 743 1.7× 118 0.7× 153 1.1× 44 1.4k
Ivo Tzvetanov United States 20 594 0.8× 774 1.2× 506 1.2× 240 1.3× 460 3.3× 85 1.4k
J. Foutz United States 9 674 0.9× 940 1.5× 373 0.8× 417 2.3× 186 1.3× 15 1.6k
Jacqueline van de Wetering Netherlands 19 594 0.8× 417 0.6× 429 1.0× 62 0.3× 139 1.0× 95 1.3k
Jeffrey Schiff Canada 18 612 0.8× 468 0.7× 205 0.5× 84 0.5× 148 1.1× 46 1.2k
Ruth Sapir‐Pichhadze Canada 19 738 1.0× 439 0.7× 302 0.7× 91 0.5× 94 0.7× 76 1.1k

Countries citing papers authored by Mark I. Aeder

Since Specialization
Citations

This map shows the geographic impact of Mark I. Aeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark I. Aeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark I. Aeder more than expected).

Fields of papers citing papers by Mark I. Aeder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark I. Aeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark I. Aeder. The network helps show where Mark I. Aeder may publish in the future.

Co-authorship network of co-authors of Mark I. Aeder

This figure shows the co-authorship network connecting the top 25 collaborators of Mark I. Aeder. A scholar is included among the top collaborators of Mark I. Aeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark I. Aeder. Mark I. Aeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anteby, Roi, E. Christopher Ellison, Emil Petrusa, et al.. (2023). Preparing to retire from surgery: a national survey. Global Surgical Education - Journal of the Association for Surgical Education. 2(1). 1 indexed citations
2.
Stewart, Darren, et al.. (2017). New Insights Into the Alleged Kidney Donor Profile Index Labeling Effect on Kidney Utilization. American Journal of Transplantation. 17(10). 2696–2704. 38 indexed citations
3.
Formica, Richard N., Mark I. Aeder, Anna Y. Kucheryavaya, et al.. (2015). Simultaneous Liver–Kidney Allocation Policy: A Proposal to Optimize Appropriate Utilization of Scarce Resources. American Journal of Transplantation. 16(3). 758–766. 125 indexed citations
4.
Hricik, Donald E., Joshua J. Augustine, Thomas C. Knauss, et al.. (2007). Long-Term Graft Outcomes After Steroid Withdrawal in African American Kidney Transplant Recipients Receiving Sirolimus and Tacrolimus. Transplantation. 83(3). 277–281. 27 indexed citations
5.
Augustine, Joshua J., Peter C. Chang, Thomas C. Knauss, et al.. (2006). Improved Renal Function after Conversion from Tacrolimus/Sirolimus to Tacrolimus/Mycophenolate Mofetil in Kidney Transplant Recipients. Transplantation. 81(7). 1004–1009. 18 indexed citations
6.
Bryan, Christopher, Alan M. Luger, Charles F. Shield, et al.. (2006). Successful renal transplantation despite low levels of donor‐specific HLA class I antibody without IVIg or plasmapheresis. Clinical Transplantation. 20(5). 563–570. 9 indexed citations
7.
Peters, Thomas G., John C West, Mark I. Aeder, et al.. (2004). Differences in Patient and Transplant Professional Perceptions of Immunosuppression-Induced Cosmetic Side Effects. Transplantation. 78(4). 537–543. 33 indexed citations
8.
Bryan, Christopher, Wida S. Cherikh, Yulin Cheng, et al.. (2004). ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney. Clinical Transplantation. 18(s12). 55–60. 4 indexed citations
9.
Bryan, Christopher, Gary E. Tegtmeier, Daniel Murillo, et al.. (2004). The risk for Chagas' disease in the Midwestern United States organ donor population is low. Clinical Transplantation. 18(s12). 12–15. 11 indexed citations
10.
Nelson, Paul W., Charles F. Shield, Nicolas Muruve, et al.. (2003). Point‐of‐care testing in an organ procurement organization donor management setting. Clinical Transplantation. 17(s9). 48–51. 7 indexed citations
11.
Bryan, Christopher, Alan M. Luger, Mark I. Aeder, et al.. (2002). Flow cytometry beads rather than the antihuman globulin method should be used to detect HLA Class I IgG antibody (PRA) in cadaveric renal regraft candidates. Clinical Transplantation. 16(s7). 15–23. 7 indexed citations
12.
Bryan, Christopher, Alan M. Luger, John Martinez, et al.. (2001). COLD ISCHEMIA TIME: AN INDEPENDENT PREDICTOR OF INCREASED HLA CLASS I ANTIBODY PRODUCTION AFTER REJECTION OF A PRIMARY CADAVERIC RENAL ALLOGRAFT1. Transplantation. 71(7). 875–879. 56 indexed citations
13.
Muruve, Nicolas, Thomas S. Helling, Alan M. Luger, et al.. (2001). Effect of donor brain-death duration on graft outcome. Transplantation Proceedings. 33(6). 2980–2981. 13 indexed citations
14.
Bryan, Christopher, Nicolas Muruve, Gilbert Ross, et al.. (2001). IgM antibodies identified by a DTT‐ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype*. Clinical Transplantation. 15(s6). 28–35. 32 indexed citations
15.
Bryan, Christopher, Charles F. Shield, Paul W. Nelson, et al.. (1998). TRANSPLANTATION RATE OF THE BLOOD GROUP B WAITING LIST IS INCREASED BY USING A2 AND A2B KIDNEYS1. Transplantation. 66(12). 1714–1717. 20 indexed citations
16.
Nelson, Paul W., Michael D. Landreneau, Alan M. Luger, et al.. (1998). TEN-YEAR EXPERIENCE IN TRANSPLANTATION OF A2KIDNEYS INTO B AND O RECIPIENTS1. Transplantation. 65(2). 256–260. 79 indexed citations
17.
Bryan, Christopher, Paul W. Nelson, Alan M. Luger, et al.. (1998). LONG-TERM GRAFT SURVIVAL IS IMPROVED IN CADAVERIC RENAL RETRANSPLANTATION BY FLOW CYTOMETRIC CROSSMATCHING1. Transplantation. 66(12). 1827–1832. 63 indexed citations
18.
Bryan, Christopher, Gary E. Tegtmeier, A. Polito, et al.. (1996). Evaluation of the 3.0 Ortho EIA assay in 385 consecutive cadaveric organ donors.. PubMed. 28(1). 155–6.
19.
Graham, W. K., et al.. (1996). Streamlining the donor organ placement process: use of portable computers in the field.. PubMed. 28(1). 217–8. 1 indexed citations
20.
Nelson, Paul W., George E. Pierce, Gilbert Ross, et al.. (1996). HLA-DR AND DQ TYPING BY POLYMERASE CHAIN REACTION USING SEQUENCE-SPECIFIC PRIMER MIXES REDUCES THE INCIDENCE OF PHENOTYPIC HOMOZYGOSITY (BLANKS) OVER SEROLOGY1. Transplantation. 62(12). 1819–1824. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dolores Prats Breakdown of academic impact, for papers by F. Oppenheimer Breakdown of academic impact, for papers by Geoffrey K. Dube Breakdown of academic impact, for papers by Jerry McCauley Breakdown of academic impact, for papers by Erica Hartmann Breakdown of academic impact, for papers by Ivo Tzvetanov Breakdown of academic impact, for papers by J. Foutz Breakdown of academic impact, for papers by Jacqueline van de Wetering Breakdown of academic impact, for papers by Jeffrey Schiff Breakdown of academic impact, for papers by Ruth Sapir‐Pichhadze
Rankless by CCL
2026